Risk and Protective Factors Associated With HIV-Related Mortality in Children Receiving Antiretroviral Therapy
JAMA Pediatrics 10.1001/jamapediatrics.2026.1235May 04, 2026 at 11:00 AM EDT
Which modifiable risk and protective factors are associated with HIV-related mortality among children and young adolescents receiving antiretroviral therapy (ART)?In this model-based meta-regression analysis linking data from 67 cohort studies of pediatric HIV-related mortality with Global Burden of Disease study covariates, access to improved water, pneumococcal conjugate vaccine third-dose (PCV3) coverage, and maternal education were the strongest protective factors. Simulated increases in these covariates showed substantial reductions in the odds of mortality.This study found that interventions to expand access to clean water, vaccination, and maternal education may foster protective environments that reduce disparities in survival outcomes among children and adolescents living with HIV who are receiving ART.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.